Canopy Growth Corp., the largest of Canada's publicly traded marijuana companies, is preparing to export its expertise through a new Brazilian partnership.

Canopy's Bedrocan subsidiary and its Brazilian partners have created a new company to import proprietary varieties of cannabis into Brazil — a country with a population of 200 million.

Initially, Bedrocan Brazil will import cannabis products into Brazil from Canada or the Netherlands.

Eventually, the company will establish domestic cultivation facilities in Brazil using Bedrocan's genetic material and cultivation technology.

The Canadian company will also partner with Sao Paulo-based Entourage Phytolab SA to develop medical cannabis products for the Brazilian and international markets.

Marijuana is still categorized as more dangerous than cocaine, methamphetamine, and PCP.

Marijuana continues to gain its status as an effective treatment for a number of health conditions, from epilepsy to the severe pain experienced by chronic cancer patients. As of today, 23 states, as well as the District of Columbia and Puerto Rico, have legalized Cannabis sativa to benefit people suffering from a number of medical conditions.

After months of public input highlighting concerns about the proposed rules and regulations surrounding medical marijuana, it seems legislators are willing to throw the rules out entirely and start with a clean slate.

Sen. Tina Muña-Barnes said she will be complying with a recommendation to reject the rules and will be facilitating amendments to the enabling statute, the Joaquin “KC” Concepcion II Compassionate Cannabis Use Act of 2013.

Sen. Dennis Rodriguez, chairman of the legislative committee on health, stated in a release yesterday that he is recommending the rejection of the rules because they contain provisions outside of or in addition to statute.

GW Pharmaceuticals gwph could be on its way to eventually winning the first U.S. approval for a marijuana-based prescription drug.

The U.K.-based biopharma on Monday unveiled more data finding that its investigational therapy Epidiolex, which is derived from a marijuana component called cannabidiol, or CBD, helped significantly reduce the number of monthly seizures suffered by patients with Lennox-Gastaut syndrome (LGS)—a rare disease that often strikes during childhood and usually causes debilitating epileptic episodes. It afflicts about 30,000 children and adults in the U.S., according to the LGS Foundation.

New Delhi: One must have seen naga babas consuming marijuana. Consumption of Cannabis is legal in various states across the United States of America and some other European countries, but that of course comes with T&C applied.

Here, we bring you some countries where consumption of marijuana is legal:

Czech Republic:

Marijuana is legal in this European country that permits its possession up to 15 grams. It has been legalised for medical use on prescription since 2013.

An attorney appointed last year by Gov. Bruce Rauner to lead the Illinois medical marijuana program has resigned to pursue work in the private sector.

Joseph Wright, 32, who was in the position for just over one year, told The Associated Press on Monday he felt the time was right to seek other opportunities, possibly in the medical cannabis industry.

A spokeswoman for the governor confirmed the resignation Monday. Spokeswoman Catherine Kelly told the AP the governor's office "will have no further comment" on the reasons for the resignation.

Toronto begins to look at dispensary regulations, US FDA learns about the MMPR, Canadian researchers in Poland, a possible task force announcement and more.

It’s a big week for those focussed on cannabis and cannabis policy in Canada. Several meetings and expected announcements, as well as one possible discussion are lined up for this last week in June.

The government has approved a plan that will remove many of the restrictions on growing medical marijuana and make it more readily available to over 23,000 patients in Israel.

According to the proposal, initiated by Health Minister Yaakov Litzman (United Torah Judaism), there will be no limit on the number of growers, there will be more doctors who can issue prescriptions, and cannabis will be available in pharmacies.

GW Pharmaceuticals (GWPH) announced positive results Monday from a second, pivotal clinical trial involving children with a severe form of epilepsy treated with its experimental marijuana-based drug.

Shares of GW Pharma are up 16% to $96.52 in Monday pre-market trading.

In the phase III study, treatment with the GW Pharma drug epidiolex resulted in a 44% reduction in monthly drop seizures compared to a 22% reduction for placebo. The difference was statistically significant.

The Department of Agriculture and Forestry gave the necessary opportunity for Louisiana State University and Southern University first right of withholding and both institutions have expressed their interest in moving forward.

After their Friday meeting, Dr. Adell Brown, Southern's Interim Chancellor, stated that the institution has come up to a decision to submit a letter stating they will accept becoming the cultivator of Louisiana state, The Times reported.